为了在沙特阿拉伯获得制药产品的管理入口协议努力协同发挥作用的战略框架 - - 这是多方利益相关者研讨会的结果
Hussain Abdulrahman Al-Omar1, Asma Abdulaziz Almuhsin2, Lolwa Hamad Almudaiyan3
1Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Journal of medical economics
|May 15, 2025
概括
管理入口协议 (MEA) 增强患者获得创新药物的机会,同时确保财务可持续性. 沙特特定的框架对于在该国医疗保健系统中有效实施MEA至关重要.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 进入市场的市场准入权.
背景情况:
- 管理入口协议 (MEA) 对于平衡患者获得治疗的机会与医疗保健系统的财务可持续性至关重要.
- 有效的MEA实施需要纳入国家定价,报销和市场准入框架.
- 本研究的重点是为沙特阿拉伯制定一个特定的国家MEA框架.
研究的目的:
- 为沙特阿拉伯制药产品提供管理入口协议 (MEA) 的国家具体框架.
- 确定在沙特阿拉伯背景下最佳实施MEA的关键推动因素.
- 解决将MEA整合到国家医疗保健系统中的挑战和机会.
主要方法:
- 一种混合方法的方法,结合了系统的文献审查和利雅得的多方利益相关者研讨会.
- 研讨会的参与者包括参与制药市场准入的政府,准政府和私营部门的代表.
- 通过一组经过验证的问题指导,对数字记录的研讨会讨论进行主题分析.
主要成果:
- 10个关键主题出现,包括获得创新药物,利益相关者的观点,早期对话,优先考虑,监管格局,框架设计,支付模式,治理,实施挑战和参与.
- 在沙特阿拉伯,MEAs被视为管理获得高成本治疗的战略工具.
- 为了成功实施MEA,一个强大的,沙特特定的框架与定规则是必不可少的.
结论:
- 管理入口协议 (MEA) 对于沙特阿拉伯的卫生系统来说至关重要,它可以在保持财务可持续性的同时获得创新疗法.
- 为了优化访问,可持续性和公平性,需要一个明确的,针对沙特阿拉伯的MEA框架,得到明确的法规和政策的支持.
- 沙特阿拉伯需要敏捷,根据证据适应的MEA政策,以应对药物治疗日益复杂的问题.
相关概念视频
Structure-Activity Relationships and Drug Design
474
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
474
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Drug Control Governance: Regulatory Bodies and Their Impact
134
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
134
Prescription, Nonprescription and Orphan Drugs
676
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
676
Drug Administration and Therapy Phases: Overview
402
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
402
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K


